---

• Palo Alto, CA


• Contact:
  Ron Eastman
  
• www.openmonoclonaltechnology.com
• Acquired by: Ligand Pharmaceuticals
• Exit date: December 11, 2015
• 

Related News

• OMT Therapeutics Announces UniRat Alliance with Caltech
• ‘Rat” Gain:  OMT Developing Alternative to Mouse mAbs
• Open Monoclonal Technology Announces OmniAb Alliance with Celgene
• OMT Announces New Antibody Discovery Program